Global Mouth Devices for Sleep Apnea Market Size By Type (Positive Airway Pressure (PAP) Devices, Masks), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Mouth Devices for Sleep Apnea Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.3 billion by 2031, expanding at a CAGR of 9.2% during the forecast period from 2023 to 2031. This growth is fueled by the rising prevalence of sleep apnea globally, increasing awareness of non-invasive treatment alternatives, and technological advancements in oral appliance therapy. Mouth devices such as mandibular advancement devices (MADs) and tongue-retaining devices (TRDs) are gaining popularity as effective and user-friendly treatments, especially for patients with mild to moderate obstructive sleep apnea (OSA).

Drivers:

1. Rising Prevalence of Sleep Apnea:

Sleep apnea affects hundreds of millions globally, with OSA being the most common type. Increased diagnosis and clinical awareness are propelling the demand for oral therapeutic solutions, particularly among patients seeking alternatives to CPAP (Continuous Positive Airway Pressure) therapy.

2. Growing Preference for Non-Invasive Therapies:

Mouth devices offer a less invasive, more comfortable solution compared to CPAP machines. Patient compliance is notably higher with oral appliances, especially for those with travel needs or discomfort with masks and airflow systems.

3. Technological Advancements:

Customized and digitally designed mouth devices using 3D imaging, AI-aided diagnostics, and intraoral scanning technologies are enhancing fit, efficacy, and patient satisfaction.

Restraints:

1. Limited Efficacy in Severe Cases:

Mouth devices are most effective for mild to moderate OSA and are less preferred for severe cases, where CPAP or surgical options are typically recommended. This limits their use in a subset of patients.

2. Reimbursement and Insurance Challenges:

In some regions, inadequate insurance coverage or reimbursement for oral appliances may hinder accessibility, especially for lower-income populations.

Opportunity:

1. Expansion in Home Healthcare and Telemedicine:

The rise of home-based sleep diagnostics and virtual consultations is creating a conducive environment for the prescription and remote fitting of mouth devices.

2. Increasing Adoption in Emerging Markets:

Improving healthcare infrastructure and growing awareness in countries across Asia-Pacific and Latin America are driving market penetration and opening lucrative avenues for key players.

Market by System Type Insights:

The Mandibular Advancement Devices (MADs) segment dominated the market in 2023, accounting for over 70% of the revenue share. MADs reposition the lower jaw forward to prevent airway obstruction, making them more widely adopted than TRDs due to their greater comfort and customization options. However, the Tongue Retaining Devices (TRDs) segment is gaining traction among edentulous patients and those with intolerance to MADs.

Market by End-use Insights:

Sleep Clinics represented the largest end-use segment in 2023, driven by the increasing number of sleep centers offering diagnostic and therapeutic services under one roof. Homecare Settings are expected to witness the fastest growth, supported by patient-friendly designs, rising telehealth utilization, and growing preference for at-home sleep management solutions.

Market by Regional Insights:

North America led the global market in 2023, owing to high diagnosis rates, favorable reimbursement policies, and a strong presence of key players. Meanwhile, the Asia-Pacific region is anticipated to record the highest CAGR through 2031, bolstered by large undiagnosed populations, increased healthcare investments, and growing awareness campaigns about sleep disorders.

Competitive Scenario:

Prominent players in the Global Mouth Devices for Sleep Apnea Market include ResMed Inc., SomnoMed, ProSomnus Sleep Technologies, Panthera Dental, Apnea Sciences Corporation, Whole You Inc., and Koninklijke Philips N.V. These companies are focusing on product innovation, digital customization, and strategic partnerships with dental professionals and sleep centers.

Key Developments Include:

2023: ProSomnus launched a digitally manufactured precision oral device integrated with telemonitoring capabilities.

2024: SomnoMed announced FDA approval for its new intraoral device, SomnoDent Avant, tailored for high patient comfort.

2025: ResMed expanded its partnership with telehealth providers to enable remote prescription and device fitting services for sleep apnea treatment.

Scope of Work – Global Mouth Devices for Sleep Apnea Market

Report Metric Details

Market Size (2023) USD 2.1 billion

Projected Market Size (2031) USD 4.3 billion

CAGR (2023–2031) 9.2%

Market Segments By System Type (MADs, TRDs), By End-use (Sleep Clinics, Homecare Settings), By Region

Growth Drivers Rising sleep apnea prevalence, demand for non-invasive therapies, technological advancements

Opportunities Homecare and telehealth adoption, growth in emerging markets

FAQs:

1) What is the current market size of the Global Mouth Devices for Sleep Apnea Market?

The market was valued at USD 2.1 billion in 2023.

2) What is the major growth driver of the Global Mouth Devices for Sleep Apnea Market?

The primary growth driver is the rising prevalence of sleep apnea and the increasing preference for non-invasive oral appliances.

3) Which is the largest region during the forecast period in the Global Mouth Devices for Sleep Apnea Market?

North America is expected to maintain its lead, supported by advanced diagnostic infrastructure and high patient awareness.

4) Which segment accounted for the largest market share in the Global Mouth Devices for Sleep Apnea Market?

The Mandibular Advancement Devices (MADs) segment held the largest market share in 2023.

5) Who are the key market players in the Global Mouth Devices for Sleep Apnea Market?

Key players include ResMed Inc., SomnoMed, ProSomnus Sleep Technologies, Panthera Dental, and Whole You Inc.